Steep Hill, Eybna Partner to Commercialize Customized Cannabis Terpene Products

Nov 27, 2017 | Original story from Steep Hill

Steep Hill, Eybna Partner to Commercialize Customized Cannabis Terpene Products

Credit: Steep Hill

Jmîchaeĺe Keller, President and CEO of Steep Hill and Nadav Eyal, Co-founder and CEO of Eybna have announced that Steep Hill and Eybna Technologies Ltd., have partnered on the first technology to produce custom terpene formulations for incorporation into cannabis-derived products.


Eybna is a global leader in the research and development of terpene-based solutions, with the mission of bringing a native product experience to users of extracted and processed cannabis products by addition of terpenes. They have now developed an extension to their core product line, called Delta.  Delta is a customized terpene formulation service that enables brands and manufacturers to customize and augment the terpene experience to realize a best-use profile for their customers. The partnership will utilize Steep Hill's expertise in analytical testing for cannabis and cannabis-derived products to customize Eybna's production of terpene formulations for optimizing the medical benefits of cannabis. Initially, Delta will be available in California, Washington, New Mexico, Alaska, Hawaii and Maryland, with numerous states and countries coming on-line in 2018.


In making the announcement, Co-founder and CEO of Eybna, Nadav Eyal said, "Using analysis from Steep Hill, Eybna will design a customized terpene formulation to assemble the exact materials lost within the process of cannabis extraction using terpenes from natural, non-cannabis origins. This formulation will be tailor-made to provide an optimal terpene mixture in the final product in order to approximate a 'whole plant' consumer experience. As core to our company's mission, we are already seeing very positive results in our terpene product lines and as we release the Delta product, together we have the potential of changing the lives of millions of consumers worldwide."


Jmîchaeĺe Keller of Steep Hill said, "The significance of this partnership is enormous for medical patients and cannabis consumers around the globe.  For those of us who have worked tirelessly for safety and accuracy in the cannabis market, this product will offer consumers safe, tested, and customized terpene mixtures to return processed cannabis products more closely to the native plant.  Some estimates place the number of terpenoids in cannabis at greater than 400, with specific terpenes such as Myrcene, Caryophyllene, Pinene having well documented medicinal benefits. This is a transforming moment for both companies and fits our mission to expand access of this powerful plant to those who need it for their health around the globe."


This article has been republished from materials provided by Steep Hill. Note: material may have been edited for length and content. For further information, please contact the cited source.